Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v5-EN
Language French English
Date Updated 2018-03-16 2017-08-25
Drug Identification Number 01918338 01918338
Brand name COUMADIN TAB 2MG COUMADIN TAB 2MG
Common or Proper name Warfarin sodium Warfarin sodium
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients WARFARIN SODIUM WARFARIN SODIUM
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1 BTL x 250's only 1 BTL x 250's only
ATC code B01AA B01AA
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-01-31 2018-01-31
Actual discontinuation date 2018-02-28
Remaining supply date 2018-02-28 2018-01-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments The Coumadin 2mg bottles of 100 will continue to be available. The Coumadin 2mg bottles of 100 will continue to be available.
Health Canada comments